2 months ago
JAZZ
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 11%
#564 out of 5557 analysts
Average Return
+13.13%
Win Rate
61%66 out of 109
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Axsome Therapeutics IncAXSM | +106.13% | $103.26 | $212.85 | 2025-08-06 - 2026-08-05 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +103.02% | $16.56 | $33.62 | 2025-06-26 - 2026-06-25 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
2 months ago
TEVA
3 months ago
ACAD
3 months ago
AMRX
4 months ago
MPLT
4 months ago
AMRX
4 months ago
CYTK
5 months ago
LEGN
6 months ago
JAZZ
6 months ago
CORT
6 months ago
ALKS
6 months ago
TEVA
7 months ago
RPRX
7 months ago
AXSM
10 months ago
AXSM
a year ago
JAZZ
a year ago
ABBV
a year ago
NBIX
a year ago
TEVA
2 years ago
TEVA
3 years ago
LEGN
3 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | 9 | Strong Buy | $239.00 | +60.14% | Maintains | 9 days ago |
Assembly Biosciences IncASMB | 2 | Strong Buy | $48.00 | +114.57% | Maintains | 9 days ago |
Acadia Pharmaceuticals IncACAD | 11 | Hold | $23.00 | +25.20% | Downgrades | a month ago |
Viatris IncVTRS | 3 | Strong Buy | $26.00 | +23.46% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 13 | Strong Buy | $214.00 | +22.70% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 9 | Strong Buy | $337.00 | +35.76% | Maintains | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 12 | Strong Buy | $48.00 | +11.01% | Maintains | 2 months ago |
Maplight Therapeutics IncMPLT | 3 | Hold | $13.00 | +73.80% | Downgrades | 3 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $25.00 | +15.15% | Maintains | 3 months ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Hold | $85.00 | +0.06% | Downgrades | 3 months ago |
Legend Biotech CorpLEGN | 6 | Hold | $28.00 | +43.30% | Downgrades | 4 months ago |
Exelixis IncEXEL | 6 | Hold | $52.00 | -26.45% | Maintains | 4 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $115.00 | +96.48% | Upgrades | 4 months ago |
Incyte CorpINCY | 4 | Hold | $113.00 | -7.58% | Maintains | 5 months ago |
Corcept Therapeutics IncCORT | 2 | Strong Buy | $72.00 | -3.39% | Upgrades | 6 months ago |
Alkermes PLCALKS | 6 | Strong Buy | $48.00 | +0.23% | Maintains | 6 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | -18.58% | Maintains | 7 months ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +21.95% | Maintains | 8 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +18.36% | Maintains | 8 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +34.42% | Downgrades | 9 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +78.05% | Maintains | 10 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | -27.58% | Downgrades | a year ago |
Abbvie IncABBV | 1 | Hold | $220.00 | N/A | Maintains | a year ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | N/A | Downgrades | a year ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | N/A | Maintains | a year ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | 2 years ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.